CompletedNCT01188694

Enhancing Extinction Learning in PTSD (PTSD)

Medication studyAges 18–65United States

The study in practice

Understand this study

Listed age limits: 18 years to 65 years.

Listed locations: Philadelphia, United States · Austin, United States and 1 more locationSee all locations and recruitment
Activities: Medication described in the protocol · Placebo comparator · Behavioural activities described in the protocol
Compensation: Payment and expense reimbursement have not been verified.

Study clarity

Study start dateSeptember 2009

Recruitment status: Completed
Enrollment listed in the registry: 42
Sponsor: University of Washington
Sponsor type: University
Study type: Behavioral
Intervention type: Psychotherapy / behavioral intervention, Medication / drug
Study phase: Phase 2
Locations: United States
Age range: From 18 Years to 65 Years
Official registry ID: NCT01188694
Official title: Show the full official title
Enhancing Extinction Learning in Post Traumatic Stress Disorder (PTSD)

Completed

Philadelphia · Austin · Seattle

FAQ

Who is behind this study?

The study sponsor is University of Washington, a university.

Did this study involve medication?

Yes. The study involved medication, including Psychotherapy plus Methylene Blue, USP.

Who was this study for?

Listed age limits: 18 years to 65 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.